Z-1480-2018 Class II Terminated

Recalled by Life Technologies Corporation — Frederick, MD

FDA device recall Z-1480-2018 was initiated by Life Technologies Corporation on Feb 8, 2018 and is designated Class II. Reason for recall: The lower concentration of the RNA panel could cause a NO CALL or FALSE NEGATIVE for the reporting of ROS1 fusion. If a physician relies on a false negative result, crizotinib could be improperly… The recall status is terminated (terminated May 12, 2020). Affected quantity: 30.

Recall details

Product Type
Devices
Report Date
May 2, 2018
Initiation Date
Feb 8, 2018
Termination Date
May 12, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
30

Product description

Oncomine Dx Target Test, (Model No. A32451), Oncomine Dx Target RNA/DNA Panel (Model No. A32441). A qualitative In Vitro Diagnostic test.

Reason for recall

The lower concentration of the RNA panel could cause a NO CALL or FALSE NEGATIVE for the reporting of ROS1 fusion. If a physician relies on a false negative result, crizotinib could be improperly excluded from the patient's treatment regimen.

Distribution pattern

Distributed to states: AZ, CA, NC, TX, and VA.

Code information

Lot 1705001 UDI: (01)10190302006385(17)180220(10)1705001(240)A32441

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1480-2018
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Life Technologies Corporation? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for Z-1480-2018. Report a data issue: hello@regdatalab.com.